MASSACHUSETTS GENERAL HOSPITAL
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Optimized Health-Related Social Needs Screening and Community Linkages
Not Applicable
Completed
- Conditions
- Emergencies
- Interventions
- Other: Written HRSN screeningOther: Oral HRSN screening
- First Posted Date
- 2019-02-08
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 236
- Registration Number
- NCT03834441
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Periconception PrEP for HIV-exposed Ugandan Women
Not Applicable
Completed
- Conditions
- HIV Prevention
- Interventions
- Behavioral: Safer conception counseling inclusive of periconception PrEP
- First Posted Date
- 2019-02-06
- Last Posted Date
- 2021-05-26
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT03832530
- Locations
- πΊπ¬
Mbarara University of Science and Technology, Mbarara, Uganda
Positron Emission Tomography (PET) Imaging of Thrombosis
Phase 1
Recruiting
- Conditions
- COVID-19CancerAtrial FibrillationThrombosis
- Interventions
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 165
- Registration Number
- NCT03830320
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Pilot Study for OCT Guided in Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
Not Applicable
Recruiting
- Conditions
- Barrett Esophagus
- Interventions
- Device: IVLCM tethered capsule
- First Posted Date
- 2019-02-05
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03830801
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
Not Applicable
Completed
- Conditions
- Genetic Predisposition to DiseaseHereditary Disease
- Interventions
- Genetic: Whole Genome Sequencing
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2020-11-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT03829176
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism
Not Applicable
Not yet recruiting
- Conditions
- Autism Spectrum Disorder
- Interventions
- Other: 20 Hz Auricular transcutaneous electrical nerve stimulationOther: 1 Hz Auricular transcutaneous electrical nerve stimulation
- First Posted Date
- 2019-02-04
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT03827941
Growth Hormone Dynamics and Cardiac Steatosis in HIV
Completed
- Conditions
- Cardiac DiseaseHuman Immunodeficiency VirusLipodystrophy
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 23
- Registration Number
- NCT03826160
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Optimizing mHealth for Adherence Monitoring and Intervention
Not Applicable
Completed
- Conditions
- HIV/AIDS
- Interventions
- Device: MERM - medication event reminder monitor
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2022-12-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 174
- Registration Number
- NCT03825952
- Locations
- πΊπ¬
Kabwohe Clinical Research Center, Kabwohe, Sheema District, Uganda
A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy
Not Applicable
Active, not recruiting
- Conditions
- Breast Cancer
- Interventions
- Device: DBT-TOBIDevice: MRI-TOBI
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2025-02-27
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT03822312
- Locations
- πΊπΈ
Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
Phase 4
Completed
- Conditions
- Type 2 Diabetes MellitusInsomniaSleep DisorderInflammation
- Interventions
- Other: Placebo
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 108
- Registration Number
- NCT03818581
- Locations
- πΊπΈ
Massachusetts General Hospital, Boston, Massachusetts, United States
Β© Copyright 2025. All Rights Reserved by MedPath